Trastuzumab Terminated Phase N/A Trials for Cancer, Breast

IndicationsStatusPurposePhase
TerminatedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01187381An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer